Moreover, the survival of patients with early gastric cancer (stage 1) was dramatically better (P < 0.00001) in H. pylori-infected patients with a higher level of TF-specific IgG antibodies (strong responders) than in weak responders [58]. The gene discussed is TF; the disease is gastric cancer.